Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120198) titled 'A study on changes in the gastrointestinal microecology of patients with Helicobacter pylori infection following tailored and dual therapy' on March 10.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Peking University Third Hospital
Condition:
Helicobacter pylori infection
Intervention:
Levofloxacin-containing tailored therapy group:none
Amoxicillin-dual therapy group:none
Tetracycline-dual therapy group:none
Clarithromycin-containing tailored therapy group:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-10
Target Sample Size: ...